{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T22:21:43Z","timestamp":1793830903778,"version":"4.6.1"},"reference-count":314,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,3,22]],"date-time":"2022-03-22T00:00:00Z","timestamp":1647907200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010665","name":"H2020 Marie Sk\u0142odowska-Curie Actions","doi-asserted-by":"publisher","award":["801481"],"award-info":[{"award-number":["801481"]}],"id":[{"id":"10.13039\/100010665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005940","name":"Danish Cancer Research Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005940","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007601","name":"Horizon 2020","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007601","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008363","name":"Kr\u00e6ftens Bek\u00e6mpelse","doi-asserted-by":"publisher","award":["R167-A10784"],"award-info":[{"award-number":["R167-A10784"]}],"id":[{"id":"10.13039\/100008363","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008363","name":"Kr\u00e6ftens Bek\u00e6mpelse","doi-asserted-by":"publisher","award":["R278-A16638"],"award-info":[{"award-number":["R278-A16638"]}],"id":[{"id":"10.13039\/100008363","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009708","name":"Novo Nordisk Fonden","doi-asserted-by":"publisher","award":["0058419"],"award-info":[{"award-number":["0058419"]}],"id":[{"id":"10.13039\/501100009708","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009708","name":"Novo Nordisk Fonden","doi-asserted-by":"publisher","award":["14040"],"award-info":[{"award-number":["14040"]}],"id":[{"id":"10.13039\/501100009708","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010661","name":"Horizon 2020 Framework Programme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010661","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008392","name":"Sundhed og Sygdom, Det Frie Forskningsr\u00e5d","doi-asserted-by":"publisher","award":["1030-00070B"],"award-info":[{"award-number":["1030-00070B"]}],"id":[{"id":"10.13039\/100008392","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jhep-reports.eu","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JHEP Reports"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1016\/j.jhepr.2022.100479","type":"journal-article","created":{"date-parts":[[2022,3,25]],"date-time":"2022-03-25T22:08:59Z","timestamp":1648246139000},"page":"100479","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":259,"title":["Lipid alterations in chronic liver disease and liver cancer"],"prefix":"10.1016","volume":"4","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0192-0090","authenticated-orcid":false,"given":"Bichitra","family":"Paul","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5275-992X","authenticated-orcid":false,"given":"Monika","family":"Lewinska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1760-5244","authenticated-orcid":false,"given":"Jesper B.","family":"Andersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhepr.2022.100479_bib1","first-page":"394","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.jhepr.2022.100479_bib2","doi-asserted-by":"crossref","first-page":"2913","DOI":"10.1158\/0008-5472.CAN-14-0155","article-title":"Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States","volume":"74","author":"Rahib","year":"2014","journal-title":"Cancer Res"},{"key":"10.1016\/j.jhepr.2022.100479_bib3","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1002\/ijc.31937","article-title":"Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods","volume":"144","author":"Ferlay","year":"2019","journal-title":"Int J Cancer"},{"key":"10.1016\/j.jhepr.2022.100479_bib4","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1001\/jamaoncol.2017.3055","article-title":"The burden of primary liver cancer and underlying etiologies from 1990 to 2015 at the global, regional, and national level: results from the global burden of disease study 2015","volume":"3","author":"Akinyemiju","year":"2017","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.jhepr.2022.100479_bib5","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1097\/01.sla.0000251366.62632.d3","article-title":"Cholangiocarcinoma: thirty-one-year experience with 564 patients at a single institution","volume":"245","author":"DeOliveira","year":"2007","journal-title":"Ann Surg"},{"key":"10.1016\/j.jhepr.2022.100479_bib6","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1097\/00000658-199610000-00005","article-title":"Cholangiocarcinoma. A spectrum of intrahepatic, perihilar, and distal tumors","volume":"224","author":"Nakeeb","year":"1996","journal-title":"Ann Surg"},{"key":"10.1016\/j.jhepr.2022.100479_bib7","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1053\/j.gastro.2017.06.012","article-title":"Risk of hepatocellular cancer in HCV patients treated with direct-acting antiviral agents","volume":"153","author":"Kanwal","year":"2017","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhepr.2022.100479_bib8","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1002\/hep.29466","article-title":"Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease","volume":"67","author":"Estes","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2022.100479_bib9","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/s41575-020-0310-z","article-title":"Cholangiocarcinoma 2020: the next horizon in mechanisms and management","volume":"17","author":"Banales","year":"2020","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.jhepr.2022.100479_bib10","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1085\/jgp.8.6.519","article-title":"The metabolism of tumors in the body","volume":"8","author":"Warburg","year":"1927","journal-title":"J\u00a0Gen Physiol"},{"key":"10.1016\/j.jhepr.2022.100479_bib11","doi-asserted-by":"crossref","first-page":"6975","DOI":"10.1016\/S0021-9258(20)89598-2","article-title":"Noninvasive tracing of Krebs cycle metabolism in liver","volume":"266","author":"Magnusson","year":"1991","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.jhepr.2022.100479_bib12","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1007\/s001250050892","article-title":"Non-invasive tracing of liver intermediary metabolism in normal subjects and in moderately hyperglycaemic NIDDM subjects. Evidence against increased gluconeogenesis and hepatic fatty acid oxidation in NIDDM","volume":"41","author":"Diraison","year":"1998","journal-title":"Diabetologia"},{"key":"10.1016\/j.jhepr.2022.100479_bib13","first-page":"E51","article-title":"Use of labeling pattern of liver glutamate to calculate rates of citric acid cycle and gluconeogenesis","volume":"272","author":"Large","year":"1997","journal-title":"Am J Physiol"},{"key":"10.1016\/j.jhepr.2022.100479_bib14","doi-asserted-by":"crossref","first-page":"E848","DOI":"10.1152\/ajpendo.2001.281.4.E848","article-title":"An integrated (2)H and (13)C NMR study of gluconeogenesis and TCA cycle flux in humans","volume":"281","author":"Jones","year":"2001","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.jhepr.2022.100479_bib15","first-page":"E843","article-title":"13C NMR measurements of human gluconeogenic fluxes after ingestion of [U-13C]propionate, phenylacetate, and acetaminophen","volume":"275","author":"Jones","year":"1998","journal-title":"Am J Physiol"},{"key":"10.1016\/j.jhepr.2022.100479_bib16","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1038\/s41575-019-0217-8","article-title":"Metabolic rearrangements in primary liver cancers: cause and consequences","volume":"16","author":"Satriano","year":"2019","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.jhepr.2022.100479_bib17","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1053\/j.gastro.2010.12.006","article-title":"Increased lipogenesis, induced by AKT-mTORC1-RPS6 signaling, promotes development of human hepatocellular carcinoma","volume":"140","author":"Calvisi","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhepr.2022.100479_bib18","doi-asserted-by":"crossref","first-page":"5032","DOI":"10.18632\/oncotarget.23494","article-title":"Comparison of hepatic and serum lipid signatures in hepatocellular carcinoma patients leads to the discovery of diagnostic and prognostic biomarkers","volume":"9","author":"Lu","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.jhepr.2022.100479_bib19","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1111\/j.1600-0854.2007.00689.x","article-title":"Imaging of lipid biosynthesis: how a neutral lipid enters lipid droplets","volume":"9","author":"Kuerschner","year":"2008","journal-title":"Traffic"},{"key":"10.1016\/j.jhepr.2022.100479_bib20","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1038\/nm.2492","article-title":"Adipocytes promote ovarian cancer metastasis and provide energy for rapid tumor growth","volume":"17","author":"Nieman","year":"2011","journal-title":"Nat Med"},{"key":"10.1016\/j.jhepr.2022.100479_bib21","doi-asserted-by":"crossref","first-page":"174261","DOI":"10.1016\/j.ejphar.2021.174261","article-title":"Triclosan down-regulates fatty acid synthase through microRNAs in HepG2 cells","volume":"907","author":"Sun","year":"2021","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.jhepr.2022.100479_bib22","doi-asserted-by":"crossref","first-page":"e379","DOI":"10.1002\/ctm2.379","article-title":"4-phenylbutyric acid promotes hepatocellular carcinoma via initiating cancer stem cells through activation of PPAR-alpha","volume":"11","author":"Chen","year":"2021","journal-title":"Clin Transl Med"},{"key":"10.1016\/j.jhepr.2022.100479_bib23","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1038\/s41467-017-00910-z","article-title":"The cholesterol metabolite 27 hydroxycholesterol facilitates breast cancer metastasis through its actions on immune cells","volume":"8","author":"Baek","year":"2017","journal-title":"Nat Commun"},{"key":"10.1016\/j.jhepr.2022.100479_bib24","doi-asserted-by":"crossref","first-page":"585306","DOI":"10.3389\/fnut.2020.585306","article-title":"High-fat diet promotes macrophage-mediated hepatic inflammation and aggravates diethylnitrosamine-induced hepatocarcinogenesis in mice","volume":"7","author":"Fu","year":"2020","journal-title":"Front Nutr"},{"key":"10.1016\/j.jhepr.2022.100479_bib25","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1093\/glycob\/1.6.623","article-title":"Synergistic effect of two cell recognition systems: glycosphingolipid-glycosphingolipid interaction and integrin receptor interaction with pericellular matrix protein","volume":"1","author":"Kojima","year":"1991","journal-title":"Glycobiology"},{"key":"10.1016\/j.jhepr.2022.100479_bib26","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1194\/jlr.R300004-JLR200","article-title":"Global analyses of cellular lipidomes directly from crude extracts of biological samples by ESI mass spectrometry: a bridge to lipidomics","volume":"44","author":"Han","year":"2003","journal-title":"J\u00a0Lipid Res"},{"key":"10.1016\/j.jhepr.2022.100479_bib27","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1038\/emboj.2009.6","article-title":"Accumulation of raft lipids in T-cell plasma membrane domains engaged in TCR signalling","volume":"28","author":"Zech","year":"2009","journal-title":"EMBO J"},{"key":"10.1016\/j.jhepr.2022.100479_bib28","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0076-6879(07)32007-7","article-title":"The lipid maps initiative in lipidomics","volume":"432","author":"Schmelzer","year":"2007","journal-title":"Methods Enzymol"},{"key":"10.1016\/j.jhepr.2022.100479_bib29","doi-asserted-by":"crossref","first-page":"e6261","DOI":"10.1371\/journal.pone.0006261","article-title":"Top-down lipidomics reveals ether lipid deficiency in blood plasma of hypertensive patients","volume":"4","author":"Graessler","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.jhepr.2022.100479_bib30","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1194\/jlr.E400004-JLR200","article-title":"A\u00a0comprehensive classification system for lipids","volume":"46","author":"Fahy","year":"2005","journal-title":"J\u00a0Lipid Res"},{"key":"10.1016\/j.jhepr.2022.100479_bib31","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0022-2275(20)39410-4","article-title":"Origin of hepatic triglyceride fatty acids: quantitative estimation of the relative contributions of linoleic acid by diet and adipose tissue in normal and ethanol-fed rats","volume":"13","author":"Mendenhall","year":"1972","journal-title":"J\u00a0Lipid Res"},{"key":"10.1016\/j.jhepr.2022.100479_bib32","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1172\/JCI23621","article-title":"Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease","volume":"115","author":"Donnelly","year":"2005","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jhepr.2022.100479_bib33","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/S1262-3636(07)70061-7","article-title":"Contribution of hepatic de novo lipogenesis and reesterification of plasma non esterified fatty acids to plasma triglyceride synthesis during non-alcoholic fatty liver disease","volume":"29","author":"Diraison","year":"2003","journal-title":"Diabetes Metab"},{"key":"10.1016\/j.jhepr.2022.100479_bib34","first-page":"248","article-title":"Nutrition classics from The Journal of Biological Chemistry 82:345-367, 1929. A new deficiency disease produced by the rigid exclusion of fat from the diet","volume":"31","author":"Burr","year":"1973","journal-title":"Nutr Rev"},{"key":"10.1016\/j.jhepr.2022.100479_bib35","first-page":"331","article-title":"Polyethenoid fatty acid metabolism; effect of dietary fat on polyethenoid fatty acids of rat tissues","volume":"20","author":"Rieckenhoff","year":"1949","journal-title":"Arch Biochem"},{"key":"10.1016\/j.jhepr.2022.100479_bib36","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/S0022-2275(20)37366-1","article-title":"Rates of sterol synthesis and uptake in the major organs of the rat in\u00a0vivo","volume":"22","author":"Turley","year":"1981","journal-title":"J\u00a0Lipid Res"},{"key":"10.1016\/j.jhepr.2022.100479_bib37","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1146\/annurev.cellbio.16.1.459","article-title":"The role of orphan nuclear receptors in the regulation of cholesterol homeostasis","volume":"16","author":"Repa","year":"2000","journal-title":"Annu Rev Cell Dev Biol"},{"key":"10.1016\/j.jhepr.2022.100479_bib38","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1016\/j.jhep.2015.11.004","article-title":"EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease","volume":"64","year":"2016","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhepr.2022.100479_bib39","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/nrm2330","article-title":"Membrane lipids: where they are and how they behave","volume":"9","author":"van Meer","year":"2008","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.jhepr.2022.100479_bib40","doi-asserted-by":"crossref","first-page":"3255","DOI":"10.1073\/pnas.1722323115","article-title":"Cholesterol provides nonsacrificial protection of membrane lipids from chemical damage at air-water interface","volume":"115","author":"Zhang","year":"2018","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jhepr.2022.100479_bib41","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/nrm2335","article-title":"Lipid signalling in disease","volume":"9","author":"Wymann","year":"2008","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.jhepr.2022.100479_bib42","doi-asserted-by":"crossref","first-page":"26522","DOI":"10.1074\/jbc.273.41.26522","article-title":"Generation of specific deoxynojirimycin-type inhibitors of the non-lysosomal glucosylceramidase","volume":"273","author":"Overkleeft","year":"1998","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.jhepr.2022.100479_bib43","doi-asserted-by":"crossref","first-page":"11312","DOI":"10.1074\/jbc.M211609200","article-title":"The Orphan G protein-coupled receptors GPR41 and GPR43 are activated by propionate and other short chain carboxylic acids","volume":"278","author":"Brown","year":"2003","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.jhepr.2022.100479_bib44","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/S0006-291X(03)00488-1","article-title":"Identification of a free fatty acid receptor, FFA2R, expressed on leukocytes and activated by short-chain fatty acids","volume":"303","author":"Nilsson","year":"2003","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.jhepr.2022.100479_bib45","doi-asserted-by":"crossref","first-page":"12163","DOI":"10.1073\/pnas.1322807111","article-title":"Oxysterols are agonist ligands of RORgammat and drive Th17 cell differentiation","volume":"111","author":"Soroosh","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jhepr.2022.100479_bib46","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1210\/me.2007-0383","article-title":"27-hydroxycholesterol is an endogenous selective estrogen receptor modulator","volume":"22","author":"DuSell","year":"2008","journal-title":"Mol Endocrinol"},{"key":"10.1016\/j.jhepr.2022.100479_bib47","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1038\/nm1641","article-title":"27-Hydroxycholesterol is an endogenous SERM that inhibits the cardiovascular effects of estrogen","volume":"13","author":"Umetani","year":"2007","journal-title":"Nat Med"},{"key":"10.1016\/j.jhepr.2022.100479_bib48","doi-asserted-by":"crossref","first-page":"E384","DOI":"10.1152\/ajpendo.00226.2010","article-title":"FATP2 is a hepatic fatty acid transporter and peroxisomal very long-chain acyl-CoA synthetase","volume":"299","author":"Falcon","year":"2010","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.jhepr.2022.100479_bib49","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1053\/j.gastro.2006.02.006","article-title":"Targeted deletion of FATP5 reveals multiple functions in liver metabolism: alterations in hepatic lipid homeostasis","volume":"130","author":"Doege","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhepr.2022.100479_bib50","doi-asserted-by":"crossref","first-page":"22186","DOI":"10.1074\/jbc.M803510200","article-title":"Silencing of hepatic fatty acid transporter protein 5 in\u00a0vivo reverses diet-induced non-alcoholic fatty liver disease and improves hyperglycemia","volume":"283","author":"Doege","year":"2008","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.jhepr.2022.100479_bib51","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s00535-009-0133-8","article-title":"Steatosis and hepatic expression of genes regulating lipid metabolism in Japanese patients infected with hepatitis C virus","volume":"45","author":"Yasui","year":"2010","journal-title":"J\u00a0Gastroenterol"},{"key":"10.1016\/j.jhepr.2022.100479_bib52","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1111\/j.1440-1746.2011.06801.x","article-title":"Hepatic steatosis in hepatitis B virus infected patients: meta-analysis of risk factors and comparison with hepatitis C infected patients","volume":"26","author":"Machado","year":"2011","journal-title":"J\u00a0Gastroenterol Hepatol"},{"key":"10.1016\/j.jhepr.2022.100479_bib53","first-page":"347","article-title":"Fatty infiltration of the liver and the development of cirrhosis in diabetes and chronic alcoholism","volume":"14","author":"Connor","year":"1938","journal-title":"Am J Pathol"},{"key":"10.1016\/j.jhepr.2022.100479_bib54","doi-asserted-by":"crossref","first-page":"3023","DOI":"10.1210\/jcem.87.7.8638","article-title":"Fat accumulation in the liver is associated with defects in insulin suppression of glucose production and serum free fatty acids independent of obesity in normal men","volume":"87","author":"Seppala-Lindroos","year":"2002","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.jhepr.2022.100479_bib55","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.2337\/db15-1552","article-title":"Insulin regulates hepatic triglyceride secretion and lipid content via signaling in the brain","volume":"65","author":"Scherer","year":"2016","journal-title":"Diabetes"},{"key":"10.1016\/j.jhepr.2022.100479_bib56","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s00125-005-0070-x","article-title":"Non-esterified fatty acid concentrations are independently associated with hepatic steatosis in obese subjects","volume":"49","author":"Holt","year":"2006","journal-title":"Diabetologia"},{"key":"10.1016\/j.jhepr.2022.100479_bib57","doi-asserted-by":"crossref","first-page":"154725","DOI":"10.1016\/j.metabol.2021.154725","article-title":"The S100 calcium-binding protein A11 promotes hepatic steatosis through RAGE-mediated AKT-mTOR signaling","volume":"117","author":"Teng","year":"2021","journal-title":"Metabolism"},{"key":"10.1016\/j.jhepr.2022.100479_bib58","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.humpath.2017.09.008","article-title":"Primary sclerosing cholangitis is protective against nonalcoholic fatty liver disease in inflammatory bowel disease","volume":"69","author":"Bosch","year":"2017","journal-title":"Hum Pathol"},{"key":"10.1016\/j.jhepr.2022.100479_bib59","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1002\/hep.30319","article-title":"Serum metabolites as diagnostic biomarkers for cholangiocarcinoma, hepatocellular carcinoma, and primary sclerosing cholangitis","volume":"70","author":"Banales","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2022.100479_bib60","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.1021\/acs.jproteome.0c00852","article-title":"Bile acid profiles are distinct among patients with different etiologies of chronic liver disease","volume":"20","author":"Sang","year":"2021","journal-title":"J\u00a0Proteome Res"},{"key":"10.1016\/j.jhepr.2022.100479_bib61","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1111\/j.1477-2574.2010.00207.x","article-title":"Evidence of aberrant lipid metabolism in hepatitis C and hepatocellular carcinoma","volume":"12","author":"Wu","year":"2010","journal-title":"HPB (Oxford)"},{"key":"10.1016\/j.jhepr.2022.100479_bib62","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1158\/1940-6207.CAPR-12-0001","article-title":"Resveratrol helps recovery from fatty liver and protects against hepatocellular carcinoma induced by hepatitis B virus X protein in a mouse model","volume":"5","author":"Lin","year":"2012","journal-title":"Cancer Prev Res (Phila)"},{"key":"10.1016\/j.jhepr.2022.100479_bib63","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1158\/0008-5472.CAN-07-2450","article-title":"Chemopreventive effect of silymarin on liver pathology in HBV X protein transgenic mice","volume":"68","author":"Wu","year":"2008","journal-title":"Cancer Res"},{"key":"10.1016\/j.jhepr.2022.100479_bib64","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1038\/2053","article-title":"The core protein of hepatitis C virus induces hepatocellular carcinoma in transgenic mice","volume":"4","author":"Moriya","year":"1998","journal-title":"Nat Med"},{"key":"10.1016\/j.jhepr.2022.100479_bib65","first-page":"22","article-title":"Liver lipids of patients with hepatitis B and C and associated hepatocellular carcinoma","author":"Haberl","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jhepr.2022.100479_bib66","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s12944-017-0437-2","article-title":"Serum lipid profile as a marker of liver impairment in hepatitis B Cirrhosis patients","volume":"16","author":"Arain","year":"2017","journal-title":"Lipids Health Dis"},{"key":"10.1016\/j.jhepr.2022.100479_bib67","doi-asserted-by":"crossref","first-page":"18175","DOI":"10.1038\/srep18175","article-title":"Serum metabolomics to identify the liver disease-specific biomarkers for the progression of hepatitis to hepatocellular carcinoma","volume":"5","author":"Gao","year":"2015","journal-title":"Sci Rep"},{"key":"10.1016\/j.jhepr.2022.100479_bib68","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s12944-018-0683-y","article-title":"Serum lipids as an indicator for the alteration of liver function in patients with hepatitis B","volume":"17","author":"Arain","year":"2018","journal-title":"Lipids Health Dis"},{"key":"10.1016\/j.jhepr.2022.100479_bib69","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s11306-017-1260-5","article-title":"Metabolic characterization of hepatitis B virus-related liver cirrhosis using NMR-based serum metabolomics","volume":"13","author":"Zheng","year":"2017","journal-title":"Metabolomics"},{"key":"10.1016\/j.jhepr.2022.100479_bib70","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1002\/mc.22266","article-title":"A\u00a0biphasic response pattern of lipid metabolomics in the stage progression of hepatitis B virus X tumorigenesis","volume":"55","author":"Teng","year":"2016","journal-title":"Mol Carcinog"},{"key":"10.1016\/j.jhepr.2022.100479_bib71","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1016\/j.bbalip.2018.06.002","article-title":"Complex lipid metabolic remodeling is required for efficient hepatitis C virus replication","volume":"1863","author":"Hofmann","year":"2018","journal-title":"Biochim Biophys Acta Mol Cell Biol Lipids"},{"key":"10.1016\/j.jhepr.2022.100479_bib72","doi-asserted-by":"crossref","first-page":"2228","DOI":"10.1111\/febs.12776","article-title":"Fatty acids increase hepatitis B virus X protein stabilization and HBx-induced inflammatory gene expression","volume":"281","author":"Cho","year":"2014","journal-title":"FEBS J"},{"key":"10.1016\/j.jhepr.2022.100479_bib73","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.bbrc.2014.02.068","article-title":"Involvement of cholesterol in hepatitis B virus X protein-induced abnormal lipid metabolism of hepatoma cells via up-regulating miR-205-targeted ACSL4","volume":"445","author":"Cui","year":"2014","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.jhepr.2022.100479_bib74","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1194\/jlr.M079533","article-title":"Intracellular hepatitis B virus increases hepatic cholesterol deposition in alcoholic fatty liver via hepatitis B core protein","volume":"59","author":"Wang","year":"2018","journal-title":"J\u00a0Lipid Res"},{"key":"10.1016\/j.jhepr.2022.100479_bib75","doi-asserted-by":"crossref","first-page":"42710","DOI":"10.1038\/srep42710","article-title":"Serum lipid alterations identified in chronic hepatitis B, hepatitis B virus-associated cirrhosis and carcinoma patients","volume":"7","author":"Wu","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.jhepr.2022.100479_bib76","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.3389\/fonc.2019.01069","article-title":"Metabolomic profiles for HBV related hepatocellular carcinoma including alpha-fetoproteins positive and negative subtypes","volume":"9","author":"Sun","year":"2019","journal-title":"Front Oncol"},{"key":"10.1016\/j.jhepr.2022.100479_bib77","doi-asserted-by":"crossref","first-page":"33466","DOI":"10.1074\/jbc.M109.019810","article-title":"Hepatitis C virus proteins induce lipogenesis and defective triglyceride secretion in transgenic mice","volume":"284","author":"Lerat","year":"2009","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.jhepr.2022.100479_bib78","doi-asserted-by":"crossref","first-page":"26826","DOI":"10.1038\/srep26826","article-title":"Dietary alpha-linolenic acid-rich flaxseed oil prevents against alcoholic hepatic steatosis via ameliorating lipid homeostasis at adipose tissue-liver axis in mice","volume":"6","author":"Wang","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.jhepr.2022.100479_bib79","first-page":"335","article-title":"Increased hepatocellular uptake of long chain fatty acids occurs by different mechanisms in fatty livers due to obesity or excess ethanol use, contributing to development of steatohepatitis in both settings","volume":"116","author":"Berk","year":"2005","journal-title":"Trans Am Clin Climatol Assoc"},{"key":"10.1016\/j.jhepr.2022.100479_bib80","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1002\/hep.510270423","article-title":"Ethanol up-regulates fatty acid uptake and plasma membrane expression and export of mitochondrial aspartate aminotransferase in HepG2 cells","volume":"27","author":"Zhou","year":"1998","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2022.100479_bib81","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/j.ajpath.2011.11.017","article-title":"Chronic alcohol exposure stimulates adipose tissue lipolysis in mice: role of reverse triglyceride transport in the pathogenesis of alcoholic steatosis","volume":"180","author":"Zhong","year":"2012","journal-title":"Am J Pathol"},{"key":"10.1016\/j.jhepr.2022.100479_bib82","doi-asserted-by":"crossref","first-page":"100325","DOI":"10.1016\/j.jhepr.2021.100325","article-title":"Comprehensive lipidomics reveals phenotypic differences in hepatic lipid turnover in ALD and NAFLD during alcohol intoxication","volume":"3","author":"Israelsen","year":"2021","journal-title":"JHEP Rep"},{"key":"10.1016\/j.jhepr.2022.100479_bib83","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1016\/S0016-5085(03)00276-2","article-title":"Betaine decreases hyperhomocysteinemia, endoplasmic reticulum stress, and liver injury in alcohol-fed mice","volume":"124","author":"Ji","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhepr.2022.100479_bib84","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1111\/j.1530-0277.2008.00666.x","article-title":"Effect of transgenic extrahepatic expression of betaine-homocysteine methyltransferase on alcohol or homocysteine-induced fatty liver","volume":"32","author":"Ji","year":"2008","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1016\/j.jhepr.2022.100479_bib85","doi-asserted-by":"crossref","first-page":"29342","DOI":"10.1074\/jbc.M202411200","article-title":"Ethanol induces fatty acid synthesis pathways by activation of sterol regulatory element-binding protein (SREBP)","volume":"277","author":"You","year":"2002","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.jhepr.2022.100479_bib86","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.jhep.2021.04.013","article-title":"Hepatic lipidomic remodeling in severe obesity manifests with steatosis and does not evolve with non-alcoholic steatohepatitis","volume":"75","author":"Ooi","year":"2021","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhepr.2022.100479_bib87","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1002\/hep4.1188","article-title":"Metabolomic-based noninvasive serum test to diagnose nonalcoholic steatohepatitis: results from discovery and validation cohorts","volume":"2","author":"Mayo","year":"2018","journal-title":"Hepatol Commun"},{"key":"10.1016\/j.jhepr.2022.100479_bib88","doi-asserted-by":"crossref","first-page":"103661","DOI":"10.1016\/j.ebiom.2021.103661","article-title":"The altered serum lipidome and its diagnostic potential for Non-Alcoholic Fatty Liver (NAFL)-associated hepatocellular carcinoma","volume":"73","author":"Lewinska","year":"2021","journal-title":"EBioMedicine"},{"key":"10.1016\/j.jhepr.2022.100479_bib89","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1136\/gutjnl-2018-317584","article-title":"Serum metabolites detect the presence of advanced fibrosis in derivation and validation cohorts of patients with non-alcoholic fatty liver disease","volume":"68","author":"Caussy","year":"2019","journal-title":"Gut"},{"key":"10.1016\/j.jhepr.2022.100479_bib90","series-title":"The altered serum lipidome and its diagnostic potential for Non-Alcoholic Fatty Liver (NAFL)-associated hepatocellular carcinoma","author":"Lewinska","year":"2021"},{"key":"10.1016\/j.jhepr.2022.100479_bib91","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1002\/hep.29359","article-title":"The presence and severity of nonalcoholic steatohepatitis is associated with specific changes in circulating bile acids","volume":"67","author":"Puri","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2022.100479_bib92","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1002\/hep.21763","article-title":"A\u00a0lipidomic analysis of nonalcoholic fatty liver disease","volume":"46","author":"Puri","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2022.100479_bib93","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1007\/s00125-005-1682-x","article-title":"Insulin resistance in non-diabetic patients with non-alcoholic fatty liver disease: sites and mechanisms","volume":"48","author":"Bugianesi","year":"2005","journal-title":"Diabetologia"},{"key":"10.1016\/j.jhepr.2022.100479_bib94","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1194\/jlr.M083741","article-title":"Oxidized linoleic acid metabolites induce liver mitochondrial dysfunction, apoptosis, and NLRP3 activation in mice","volume":"59","author":"Schuster","year":"2018","journal-title":"J\u00a0Lipid Res"},{"key":"10.1016\/j.jhepr.2022.100479_bib95","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1002\/hep.29914","article-title":"Neutrophil extracellular traps promote inflammation and development of hepatocellular carcinoma in nonalcoholic steatohepatitis","volume":"68","author":"van der Windt","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2022.100479_bib96","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1038\/s41419-018-0687-6","article-title":"Carnitine palmitoyltransferase gene upregulation by linoleic acid induces CD4(+) T cell apoptosis promoting HCC development","volume":"9","author":"Brown","year":"2018","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.jhepr.2022.100479_bib97","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1038\/nature16969","article-title":"NAFLD causes selective CD4(+) T lymphocyte loss and promotes hepatocarcinogenesis","volume":"531","author":"Ma","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.jhepr.2022.100479_bib98","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1038\/s41586-021-03362-0","article-title":"NASH limits anti-tumour surveillance in immunotherapy-treated HCC","volume":"592","author":"Pfister","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.jhepr.2022.100479_bib99","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1007\/s00125-009-1282-2","article-title":"Serum saturated fatty acids containing triacylglycerols are better markers of insulin resistance than total serum triacylglycerol concentrations","volume":"52","author":"Kotronen","year":"2009","journal-title":"Diabetologia"},{"key":"10.1016\/j.jhepr.2022.100479_bib100","doi-asserted-by":"crossref","first-page":"2266","DOI":"10.1007\/s00125-013-2981-2","article-title":"Prediction of non-alcoholic fatty-liver disease and liver fat content by serum molecular lipids","volume":"56","author":"Oresic","year":"2013","journal-title":"Diabetologia"},{"key":"10.1016\/j.jhepr.2022.100479_bib101","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1053\/j.gastro.2010.06.064","article-title":"Splanchnic balance of free fatty acids, endocannabinoids, and lipids in subjects with nonalcoholic fatty liver disease","volume":"139","author":"Westerbacka","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhepr.2022.100479_bib102","doi-asserted-by":"crossref","first-page":"203","DOI":"10.2337\/db08-1074","article-title":"Hepatic stearoyl-CoA desaturase (SCD)-1 activity and diacylglycerol but not ceramide concentrations are increased in the nonalcoholic human fatty liver","volume":"58","author":"Kotronen","year":"2009","journal-title":"Diabetes"},{"key":"10.1016\/j.jhepr.2022.100479_bib103","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1194\/jlr.P056002","article-title":"Biomarkers of NAFLD progression: a lipidomics approach to an epidemic","volume":"56","author":"Gorden","year":"2015","journal-title":"J\u00a0Lipid Res"},{"key":"10.1016\/j.jhepr.2022.100479_bib104","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1111\/j.1872-034X.2011.00815.x","article-title":"Weight loss amelioration of non-alcoholic steatohepatitis linked to shifts in hepatic ceramide expression and serum ceramide levels","volume":"41","author":"Promrat","year":"2011","journal-title":"Hepatol Res"},{"key":"10.1016\/j.jhepr.2022.100479_bib105","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1016\/j.jhep.2016.01.002","article-title":"Hepatic ceramides dissociate steatosis and insulin resistance in patients with non-alcoholic fatty liver disease","volume":"64","author":"Luukkonen","year":"2016","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhepr.2022.100479_bib106","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.2337\/dc17-1318","article-title":"Specific hepatic sphingolipids relate to insulin resistance, oxidative stress, and inflammation in nonalcoholic steatohepatitis","volume":"41","author":"Apostolopoulou","year":"2018","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jhepr.2022.100479_bib107","doi-asserted-by":"crossref","DOI":"10.1038\/s41575-021-00502-9","article-title":"Metabolomics and lipidomics in NAFLD: biomarkers and non-invasive diagnostic tests","author":"Masoodi","year":"2021","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.jhepr.2022.100479_bib108","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.cmet.2015.06.007","article-title":"Targeted induction of ceramide degradation leads to improved systemic metabolism and reduced hepatic steatosis","volume":"22","author":"Xia","year":"2015","journal-title":"Cell Metab"},{"key":"10.1016\/j.jhepr.2022.100479_bib109","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1126\/science.aav3722","article-title":"Targeting a ceramide double bond improves insulin resistance and hepatic steatosis","volume":"365","author":"Chaurasia","year":"2019","journal-title":"Science"},{"key":"10.1016\/j.jhepr.2022.100479_bib110","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1097\/MEG.0b013e328345c8c7","article-title":"Elevated hepatic fatty acid oxidation, high plasma fibroblast growth factor 21, and fasting bile acids in nonalcoholic steatohepatitis","volume":"23","author":"Dasarathy","year":"2011","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.jhepr.2022.100479_bib111","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1097\/MEG.0b013e3282f4710a","article-title":"Bile acid levels are increased in the liver of patients with steatohepatitis","volume":"20","author":"Aranha","year":"2008","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.jhepr.2022.100479_bib112","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0151829","article-title":"Bile acids and dysbiosis in non-alcoholic fatty liver disease","volume":"11","author":"Mouzaki","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.jhepr.2022.100479_bib113","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1053\/j.gastro.2017.01.055","article-title":"Bile acid control of metabolism and inflammation in obesity, Type 2 diabetes, dyslipidemia, and nonalcoholic fatty liver disease","volume":"152","author":"Chavez-Talavera","year":"2017","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhepr.2022.100479_bib114","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/j.cmet.2020.03.010","article-title":"Cholesterol stabilizes TAZ in hepatocytes to promote experimental non-alcoholic steatohepatitis","volume":"31","author":"Wang","year":"2020","journal-title":"Cell Metab"},{"key":"10.1016\/j.jhepr.2022.100479_bib115","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1111\/liv.12680","article-title":"Serum metabolic signatures of primary biliary cirrhosis and primary sclerosing cholangitis","volume":"35","author":"Bell","year":"2015","journal-title":"Liver Int"},{"key":"10.1016\/j.jhepr.2022.100479_bib116","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.dld.2011.10.025","article-title":"Metabolomic profiling of 17 bile acids in serum from patients with primary biliary cirrhosis and primary sclerosing cholangitis: a pilot study","volume":"44","author":"Trottier","year":"2012","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.jhepr.2022.100479_bib117","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s00216-012-5782-4","article-title":"Serum metabolomics reveals the deregulation of fatty acids metabolism in hepatocellular carcinoma and chronic liver diseases","volume":"403","author":"Zhou","year":"2012","journal-title":"Anal Bioanal Chem"},{"key":"10.1016\/j.jhepr.2022.100479_bib118","doi-asserted-by":"crossref","first-page":"4722","DOI":"10.1158\/0008-5472.CAN-12-3797","article-title":"Proteomic and lipidomic signatures of lipid metabolism in NASH-associated hepatocellular carcinoma","volume":"73","author":"Muir","year":"2013","journal-title":"Cancer Res"},{"key":"10.1016\/j.jhepr.2022.100479_bib119","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13071599","article-title":"Association between lipid profiles and the incidence of hepatocellular carcinoma: a nationwide population-based study","volume":"13","author":"Cho","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.jhepr.2022.100479_bib120","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s40170-021-00266-5","article-title":"Integration of global metabolomics and lipidomics approaches reveals the molecular mechanisms and the potential biomarkers for postoperative recurrence in early-stage cholangiocarcinoma","volume":"9","author":"Padthaisong","year":"2021","journal-title":"Cancer Metab"},{"key":"10.1016\/j.jhepr.2022.100479_bib121","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13010088","article-title":"Remodeling lipids in the transition from chronic liver disease to hepatocellular carcinoma","volume":"13","author":"Ismail","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.jhepr.2022.100479_bib122","first-page":"5536","article-title":"Reduction of polyunsaturated fatty acids with tumor progression in a lean non-alcoholic steatohepatitis-associated hepatocellular carcinoma mouse model","volume":"11","author":"Vlock","year":"2020","journal-title":"J\u00a0Cancer"},{"key":"10.1016\/j.jhepr.2022.100479_bib123","doi-asserted-by":"crossref","first-page":"18095","DOI":"10.18632\/oncotarget.7741","article-title":"Serum sphingolipidomic analyses reveal an upregulation of C16-ceramide and sphingosine-1-phosphate in hepatocellular carcinoma","volume":"7","author":"Grammatikos","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.jhepr.2022.100479_bib124","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/j.ccell.2017.11.011","article-title":"mTORC2 promotes tumorigenesis via lipid synthesis","volume":"32","author":"Guri","year":"2017","journal-title":"Cancer Cell"},{"key":"10.1016\/j.jhepr.2022.100479_bib125","doi-asserted-by":"crossref","first-page":"10814","DOI":"10.1038\/s41598-018-29144-9","article-title":"Generation of sphingosine-1-phosphate is enhanced in biliary tract cancer patients and is associated with lymphatic metastasis","volume":"8","author":"Hirose","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.jhepr.2022.100479_bib126","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1158\/1541-7786.MCR-17-0681","article-title":"S1P stimulates proliferation by upregulating CTGF expression through S1PR2-mediated YAP activation","volume":"16","author":"Cheng","year":"2018","journal-title":"Mol Cancer Res"},{"key":"10.1016\/j.jhepr.2022.100479_bib127","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1111\/j.1478-3231.2011.02666.x","article-title":"Sphingosine kinase 1 promotes tumour cell migration and invasion via the S1P\/EDG1 axis in hepatocellular carcinoma","volume":"32","author":"Bao","year":"2012","journal-title":"Liver Int"},{"key":"10.1016\/j.jhepr.2022.100479_bib128","doi-asserted-by":"crossref","first-page":"63324","DOI":"10.18632\/oncotarget.11450","article-title":"Sphingosine-1-phosphate induced epithelial-mesenchymal transition of hepatocellular carcinoma via an MMP-7\/ syndecan-1\/TGF-beta autocrine loop","volume":"7","author":"Zeng","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.jhepr.2022.100479_bib129","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.jss.2020.11.044","article-title":"Sphingosine-1-phosphate Receptor-1 promotes vascular invasion and EMT in hepatocellular carcinoma","volume":"259","author":"Yokota","year":"2021","journal-title":"J\u00a0Surg Res"},{"key":"10.1016\/j.jhepr.2022.100479_bib130","doi-asserted-by":"crossref","first-page":"579","DOI":"10.3892\/etm.2014.2137","article-title":"microRNA-148a inhibits hepatocellular carcinoma cell invasion by targeting sphingosine-1-phosphate receptor 1","volume":"9","author":"Zhang","year":"2015","journal-title":"Exp Ther Med"},{"key":"10.1016\/j.jhepr.2022.100479_bib131","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.bbrc.2020.07.099","article-title":"Blocking sphingosine 1-phosphate receptor 2 accelerates hepatocellular carcinoma progression in a mouse model of NASH","volume":"530","author":"Yoshida","year":"2020","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.jhepr.2022.100479_bib132","first-page":"1530","article-title":"Endocannabinoid system and the expression of endogenous ceramides in human hepatocellular carcinoma","volume":"18","author":"Yang","year":"2019","journal-title":"Oncol Lett"},{"key":"10.1016\/j.jhepr.2022.100479_bib133","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1016\/j.bbalip.2016.08.014","article-title":"Ceramide and polyunsaturated phospholipids are strongly reduced in human hepatocellular carcinoma","volume":"1861","author":"Krautbauer","year":"2016","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.jhepr.2022.100479_bib134","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1002\/hep.31391","article-title":"Lipid remodeling in hepatocyte proliferation and hepatocellular carcinoma","volume":"73","author":"Hall","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2022.100479_bib135","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.18632\/oncotarget.26738","article-title":"Phospholipid profiles and hepatocellular carcinoma risk and prognosis in cirrhotic patients","volume":"10","author":"Cotte","year":"2019","journal-title":"Oncotarget"},{"key":"10.1016\/j.jhepr.2022.100479_bib136","doi-asserted-by":"crossref","first-page":"4642","DOI":"10.1158\/1078-0432.CCR-16-2363","article-title":"A\u00a0phase I study of ABC294640, a first-in-class sphingosine kinase-2 inhibitor, in patients with advanced solid tumors","volume":"23","author":"Britten","year":"2017","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jhepr.2022.100479_bib137","doi-asserted-by":"crossref","first-page":"694","DOI":"10.3389\/fonc.2020.00694","article-title":"Targeting SphK2 reverses acquired resistance of regorafenib in hepatocellular carcinoma","volume":"10","author":"Shi","year":"2020","journal-title":"Front Oncol"},{"key":"10.1016\/j.jhepr.2022.100479_bib138","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1007\/s12072-020-10056-8","article-title":"Distribution and clinical relevance of phospholipids in hepatocellular carcinoma","volume":"14","author":"Liu","year":"2020","journal-title":"Hepatol Int"},{"key":"10.1016\/j.jhepr.2022.100479_bib139","doi-asserted-by":"crossref","first-page":"5433","DOI":"10.1021\/pr300683a","article-title":"Serum metabolic profiling study of hepatocellular carcinoma infected with hepatitis B or hepatitis C virus by using liquid chromatography-mass spectrometry","volume":"11","author":"Zhou","year":"2012","journal-title":"J\u00a0Proteome Res"},{"key":"10.1016\/j.jhepr.2022.100479_bib140","doi-asserted-by":"crossref","first-page":"4490","DOI":"10.1038\/s41467-018-06931-6","article-title":"Dietary cholesterol promotes steatohepatitis related hepatocellular carcinoma through dysregulated metabolism and calcium signaling","volume":"9","author":"Liang","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/j.jhepr.2022.100479_bib141","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.jhep.2018.03.011","article-title":"A\u00a0simple diet- and chemical-induced murine NASH model with rapid progression of steatohepatitis, fibrosis and liver cancer","volume":"69","author":"Tsuchida","year":"2018","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhepr.2022.100479_bib142","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1097\/MCG.0000000000001478","article-title":"Efficacy and safety of statin for hepatocellular carcinoma prevention among chronic liver disease patients: a systematic review and meta-analysis","volume":"55","author":"Wong","year":"2021","journal-title":"J\u00a0Clin Gastroenterol"},{"key":"10.1016\/j.jhepr.2022.100479_bib143","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1002\/hep.31146","article-title":"Effect of statins on the risk of extrahepatic cholangiocarcinoma","volume":"72","author":"Lavu","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2022.100479_bib144","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1016\/j.cgh.2018.12.046","article-title":"Statin use after diagnosis of hepatocellular carcinoma is associated with decreased mortality","volume":"17","author":"Thrift","year":"2019","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jhepr.2022.100479_bib145","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1053\/j.gastro.2019.01.026","article-title":"Effects of hypercholesterolemia and statin exposure on survival in a large national cohort of patients with cirrhosis","volume":"156","author":"Kaplan","year":"2019","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhepr.2022.100479_bib146","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1053\/j.gastro.2020.01.028","article-title":"High serum levels of cholesterol increase antitumor functions of nature killer cells and reduce growth of liver tumors in mice","volume":"158","author":"Qin","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhepr.2022.100479_bib147","doi-asserted-by":"crossref","first-page":"2322","DOI":"10.1002\/ijc.23307","article-title":"Serum lipid levels and the risk of biliary tract cancers and biliary stones: a population-based study in China","volume":"122","author":"Andreotti","year":"2008","journal-title":"Int J Cancer"},{"key":"10.1016\/j.jhepr.2022.100479_bib148","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13112648","article-title":"Association between pre-diagnostic serum bile acids and hepatocellular carcinoma: the Singapore Chinese health study","volume":"13","author":"Thomas","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.jhepr.2022.100479_bib149","doi-asserted-by":"crossref","first-page":"e00131","DOI":"10.14309\/ctg.0000000000000131","article-title":"Altered microbiota diversity and bile acid signaling in cirrhotic and noncirrhotic NASH-HCC","volume":"11","author":"Sydor","year":"2020","journal-title":"Clin Transl Gastroenterol"},{"key":"10.1016\/j.jhepr.2022.100479_bib150","doi-asserted-by":"crossref","first-page":"111036","DOI":"10.1016\/j.biopha.2020.111036","article-title":"The gut microbiome-bile acid axis in hepatocarcinogenesis","volume":"133","author":"Wu","year":"2021","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.jhepr.2022.100479_bib151","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1172\/JCI76738","article-title":"Intestinal farnesoid X receptor signaling promotes nonalcoholic fatty liver disease","volume":"125","author":"Jiang","year":"2015","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jhepr.2022.100479_bib152","article-title":"Histone acetylation of bile acid transporter genes plays a critical role in cirrhosis","author":"Garrido","year":"2021","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhepr.2022.100479_bib153","doi-asserted-by":"crossref","first-page":"6657","DOI":"10.4049\/jimmunol.0901347","article-title":"The bile acid sensor farnesoid X receptor is a modulator of liver immunity in a rodent model of acute hepatitis","volume":"183","author":"Mencarelli","year":"2009","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jhepr.2022.100479_bib154","doi-asserted-by":"crossref","first-page":"105775","DOI":"10.1016\/j.jsbmb.2020.105775","article-title":"Analysis of bile acid profile in plasma to differentiate cholangiocarcinoma from benign biliary diseases and healthy controls","volume":"205","author":"Zhang","year":"2021","journal-title":"J\u00a0Steroid Biochem Mol Biol"},{"key":"10.1016\/j.jhepr.2022.100479_bib155","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/1756-8722-4-41","article-title":"Impact of bile acids on the growth of human cholangiocarcinoma via FXR","volume":"4","author":"Dai","year":"2011","journal-title":"J\u00a0Hematol Oncol"},{"key":"10.1016\/j.jhepr.2022.100479_bib156","doi-asserted-by":"crossref","first-page":"111","DOI":"10.3109\/07357907.2012.762781","article-title":"Bile acids affect the growth of human cholangiocarcinoma via NF-kB pathway","volume":"31","author":"Dai","year":"2013","journal-title":"Cancer Invest"},{"key":"10.1016\/j.jhepr.2022.100479_bib157","doi-asserted-by":"crossref","first-page":"7505","DOI":"10.1073\/pnas.86.19.7505","article-title":"Promotion of murine hepatocarcinogenesis by testosterone is androgen receptor-dependent but not cell autonomous","volume":"86","author":"Kemp","year":"1989","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jhepr.2022.100479_bib158","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1038\/s41416-020-0835-5","article-title":"Exogenous hormone use, reproductive factors and risk of intrahepatic cholangiocarcinoma among women: results from cohort studies in the Liver Cancer Pooling Project and the UK Biobank","volume":"123","author":"Petrick","year":"2020","journal-title":"Br J Cancer"},{"key":"10.1016\/j.jhepr.2022.100479_bib159","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1038\/labinvest.2015.63","article-title":"Estrogen suppresses hepatocellular carcinoma cells through ERbeta-mediated upregulation of the NLRP3 inflammasome","volume":"95","author":"Wei","year":"2015","journal-title":"Lab Invest"},{"key":"10.1016\/j.jhepr.2022.100479_bib160","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1007\/s12672-018-0349-2","article-title":"The importance of CYP19A1 in estrogen receptor-positive cholangiocarcinoma","volume":"9","author":"Kaewlert","year":"2018","journal-title":"Horm Cancer"},{"key":"10.1016\/j.jhepr.2022.100479_bib161","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1007\/s00432-012-1207-1","article-title":"Estrogen is increased in male cholangiocarcinoma patients' serum and stimulates invasion in cholangiocarcinoma cell lines in\u00a0vitro","volume":"138","author":"Hunsawong","year":"2012","journal-title":"J\u00a0Cancer Res Clin Oncol"},{"key":"10.1016\/j.jhepr.2022.100479_bib162","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1158\/1078-0432.CCR-08-1150","article-title":"Molecular mechanisms of tamoxifen therapy for cholangiocarcinoma: role of calmodulin","volume":"15","author":"Pawar","year":"2009","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jhepr.2022.100479_bib163","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1038\/bjc.2015.58","article-title":"Reproductive factors, exogenous hormone use and risk of hepatocellular carcinoma among US women: results from the Liver Cancer Pooling Project","volume":"112","author":"McGlynn","year":"2015","journal-title":"Br J Cancer"},{"key":"10.1016\/j.jhepr.2022.100479_bib164","doi-asserted-by":"crossref","DOI":"10.1038\/s41568-021-00383-9","article-title":"The immunological and metabolic landscape in primary and metastatic liver cancer","author":"Li","year":"2021","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.jhepr.2022.100479_bib165","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s12887-020-02487-x","article-title":"Association of telomere length and telomerase methylation with n-3 fatty acids in preschool children with obesity","volume":"21","author":"Liu","year":"2021","journal-title":"BMC Pediatr"},{"key":"10.1016\/j.jhepr.2022.100479_bib166","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1111\/liv.13529","article-title":"Telomerase enzyme deficiency promotes metabolic dysfunction in murine hepatocytes upon dietary stress","volume":"38","author":"Alves-Paiva","year":"2018","journal-title":"Liver Int"},{"key":"10.1016\/j.jhepr.2022.100479_bib167","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/s41572-020-00240-3","article-title":"Hepatocellular carcinoma","volume":"7","author":"Llovet","year":"2021","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.jhepr.2022.100479_bib168","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1136\/gutjnl-2014-308430","article-title":"MicroRNA-21 is a potential link between non-alcoholic fatty liver disease and hepatocellular carcinoma via modulation of the HBP1-p53-Srebp1c pathway","volume":"65","author":"Wu","year":"2016","journal-title":"Gut"},{"key":"10.1016\/j.jhepr.2022.100479_bib169","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1016\/j.jcmgh.2021.07.002","article-title":"Fatty acids inhibit LAMP2-mediated autophagy flux via activating ER stress pathway in alcohol-related liver disease","volume":"12","author":"Guo","year":"2021","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"10.1016\/j.jhepr.2022.100479_bib170","doi-asserted-by":"crossref","first-page":"14752","DOI":"10.1038\/srep14752","article-title":"Elevated free fatty acid uptake via CD36 promotes epithelial-mesenchymal transition in hepatocellular carcinoma","volume":"5","author":"Nath","year":"2015","journal-title":"Sci Rep"},{"key":"10.1016\/j.jhepr.2022.100479_bib171","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1158\/0008-5472.CAN-14-2561","article-title":"Omega-3 polyunsaturated fatty acids upregulate 15-PGDH expression in cholangiocarcinoma cells by inhibiting miR-26a\/b expression","volume":"75","author":"Yao","year":"2015","journal-title":"Cancer Res"},{"key":"10.1016\/j.jhepr.2022.100479_bib172","doi-asserted-by":"crossref","first-page":"4149","DOI":"10.1038\/s41467-018-06650-y","article-title":"C16-ceramide is a natural regulatory ligand of p53 in cellular stress response","volume":"9","author":"Fekry","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/j.jhepr.2022.100479_bib173","doi-asserted-by":"crossref","first-page":"e0149462","DOI":"10.1371\/journal.pone.0149462","article-title":"Increased mRNA levels of sphingosine kinases and S1P lyase and reduced levels of S1P were observed in hepatocellular carcinoma in association with poorer differentiation and earlier recurrence","volume":"11","author":"Uranbileg","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.jhepr.2022.100479_bib174","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1159\/000233248","article-title":"A\u00a0ceramide-binding C1 domain mediates kinase suppressor of ras membrane translocation","volume":"24","author":"Yin","year":"2009","journal-title":"Cell Physiol Biochem"},{"key":"10.1016\/j.jhepr.2022.100479_bib175","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.jss.2009.09.005","article-title":"Hepatocellular carcinoma associated lipid metabolism reprogramming","volume":"169","author":"Skill","year":"2011","journal-title":"J\u00a0Surg Res"},{"key":"10.1016\/j.jhepr.2022.100479_bib176","doi-asserted-by":"crossref","first-page":"66154","DOI":"10.18632\/oncotarget.19825","article-title":"EDG2 enhanced the progression of hepatocellular carcinoma by LPA\/PI3K\/AKT\/ mTOR signaling","volume":"8","author":"Xu","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.jhepr.2022.100479_bib177","first-page":"785","article-title":"Lysophosphatidic acid enhances human hepatocellular carcinoma cell migration, invasion and adhesion through P38 MAPK pathway","volume":"59","author":"Zhu","year":"2012","journal-title":"Hepatogastroenterology"},{"key":"10.1016\/j.jhepr.2022.100479_bib178","first-page":"481","article-title":"Phosphatidylcholine induces growth inhibition of hepatic cancer by apoptosis via death ligands","volume":"56","author":"Sakakima","year":"2009","journal-title":"Hepatogastroenterology"},{"key":"10.1016\/j.jhepr.2022.100479_bib179","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1016\/j.cmet.2016.09.016","article-title":"Hepatocyte TAZ\/WWTR1 promotes inflammation and fibrosis in nonalcoholic steatohepatitis","volume":"24","author":"Wang","year":"2016","journal-title":"Cell Metab"},{"key":"10.1016\/j.jhepr.2022.100479_bib180","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/s41572-021-00300-2","volume":"7","author":"Brindley","year":"2021","journal-title":"Cholangiocarcinoma. Nat Rev Dis Primers"},{"key":"10.1016\/j.jhepr.2022.100479_bib181","doi-asserted-by":"crossref","first-page":"4300","DOI":"10.1073\/pnas.1617709114","article-title":"Oncogene KRAS activates fatty acid synthase, resulting in specific ERK and lipid signatures associated with lung adenocarcinoma","volume":"114","author":"Gouw","year":"2017","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jhepr.2022.100479_bib182","doi-asserted-by":"crossref","first-page":"5548","DOI":"10.1158\/0008-5472.CAN-17-3964","article-title":"Canonical Wnt signaling remodels lipid metabolism in zebrafish hepatocytes following ras oncogenic insult","volume":"78","author":"Yao","year":"2018","journal-title":"Cancer Res"},{"key":"10.1016\/j.jhepr.2022.100479_bib183","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.ijbiomac.2021.09.188","article-title":"p53 regulates lipid metabolism in cancer","volume":"192","author":"Chen","year":"2021","journal-title":"Int J Biol Macromol"},{"key":"10.1016\/j.jhepr.2022.100479_bib184","doi-asserted-by":"crossref","first-page":"25395","DOI":"10.1074\/jbc.M302364200","article-title":"p53 Activation in adipocytes of obese mice","volume":"278","author":"Yahagi","year":"2003","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.jhepr.2022.100479_bib185","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/j.cell.2018.11.011","article-title":"p53 represses the mevalonate pathway to mediate tumor suppression","volume":"176","author":"Moon","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.jhepr.2022.100479_bib186","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.molcel.2011.08.038","article-title":"ROS-mediated p53 induction of Lpin1 regulates fatty acid oxidation in response to nutritional stress","volume":"44","author":"Assaily","year":"2011","journal-title":"Mol Cell"},{"key":"10.1016\/j.jhepr.2022.100479_bib187","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.jhep.2012.11.042","article-title":"Inhibition of p53 attenuates steatosis and liver injury in a mouse model of non-alcoholic fatty liver disease","volume":"58","author":"Derdak","year":"2013","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhepr.2022.100479_bib188","first-page":"3789","article-title":"The role of Wnt signaling pathway in tumor metabolic reprogramming","volume":"10","author":"Mo","year":"2019","journal-title":"J\u00a0Cancer"},{"key":"10.1016\/j.jhepr.2022.100479_bib189","doi-asserted-by":"crossref","first-page":"110851","DOI":"10.1016\/j.biopha.2020.110851","article-title":"WNT\/beta-catenin signaling in the development of liver cancers","volume":"132","author":"He","year":"2020","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.jhepr.2022.100479_bib190","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1136\/gutjnl-2017-315448","article-title":"beta-catenin-activated hepatocellular carcinomas are addicted to fatty acids","volume":"68","author":"Senni","year":"2019","journal-title":"Gut"},{"key":"10.1016\/j.jhepr.2022.100479_bib191","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1038\/nrm4074","article-title":"Transcriptional regulation of hepatic lipogenesis","volume":"16","author":"Wang","year":"2015","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.jhepr.2022.100479_bib192","doi-asserted-by":"crossref","first-page":"4312","DOI":"10.1073\/pnas.94.9.4312","article-title":"Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptors alpha and delta","volume":"94","author":"Forman","year":"1997","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jhepr.2022.100479_bib193","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1186\/s12885-019-5963-z","article-title":"Sphere-forming culture enriches liver cancer stem cells and reveals Stearoyl-CoA desaturase 1 as a potential therapeutic target","volume":"19","author":"Ma","year":"2019","journal-title":"BMC Cancer"},{"key":"10.1016\/j.jhepr.2022.100479_bib194","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/s43018-020-00168-3","article-title":"LXR\u03b1 activation and Raf inhibition trigger lethal lipotoxicity in liver cancer","volume":"2","author":"Rudalska","year":"2021","journal-title":"Nat Cancer"},{"key":"10.1016\/j.jhepr.2022.100479_bib195","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1111\/jgh.15239","article-title":"Oxidative stress and Liver X Receptor agonist induce hepatocellular carcinoma in Non-alcoholic steatohepatitis model","volume":"36","author":"Shimizu","year":"2021","journal-title":"J\u00a0Gastroenterol Hepatol"},{"key":"10.1016\/j.jhepr.2022.100479_bib196","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.celrep.2018.03.077","article-title":"Molecular characterization and clinical relevance of metabolic expression subtypes in human cancers","volume":"23","author":"Peng","year":"2018","journal-title":"Cell Rep"},{"key":"10.1016\/j.jhepr.2022.100479_bib197","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1016\/j.cell.2017.05.046","article-title":"Comprehensive and integrative genomic characterization of hepatocellular carcinoma","volume":"169","author":"Ally","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.jhepr.2022.100479_bib198","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1053\/j.gastro.2013.01.054","article-title":"Integrated metabolite and gene expression profiles identify lipid biomarkers associated with progression of hepatocellular carcinoma and patient outcomes","volume":"144","author":"Budhu","year":"2013","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhepr.2022.100479_bib199","doi-asserted-by":"crossref","first-page":"7522","DOI":"10.1073\/pnas.121164498","article-title":"Tissue-specific overexpression of lipoprotein lipase causes tissue-specific insulin\u00a0resistance","volume":"98","author":"Kim","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jhepr.2022.100479_bib200","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1172\/JCI2912","article-title":"Lipoprotein lipase expression exclusively in liver. A mouse model for metabolism in the neonatal period and during cachexia","volume":"102","author":"Merkel","year":"1998","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jhepr.2022.100479_bib201","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1038\/s41419-021-03596-w","article-title":"The fatty acid receptor CD36 promotes HCC progression through activating Src\/PI3K\/AKT axis-dependent aerobic glycolysis","volume":"12","author":"Luo","year":"2021","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.jhepr.2022.100479_bib202","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.mam.2012.07.010","article-title":"SLC27 fatty acid transport proteins","volume":"34","author":"Anderson","year":"2013","journal-title":"Mol Aspects Med"},{"key":"10.1016\/j.jhepr.2022.100479_bib203","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1002\/hep.28508","article-title":"Differential requirement for de novo lipogenesis in cholangiocarcinoma and hepatocellular carcinoma of mice and humans","volume":"63","author":"Li","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2022.100479_bib204","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.jhep.2019.08.017","article-title":"Advances in molecular classification and precision oncology in hepatocellular carcinoma","volume":"72","author":"Rebouissou","year":"2020","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhepr.2022.100479_bib205","article-title":"Role of lipogenesis rewiring in hepatocellular carcinoma","author":"Zhou","year":"2021","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.jhepr.2022.100479_bib206","doi-asserted-by":"crossref","first-page":"14689","DOI":"10.1038\/ncomms14689","article-title":"Inhibition of hepatic lipogenesis enhances liver tumorigenesis by increasing antioxidant defence and promoting cell survival","volume":"8","author":"Nelson","year":"2017","journal-title":"Nat Commun"},{"key":"10.1016\/j.jhepr.2022.100479_bib207","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.hbpd.2020.05.010","article-title":"ATP-citrate lyase regulates stemness and metastasis in hepatocellular carcinoma via the Wnt\/beta-catenin signaling pathway","volume":"20","author":"Han","year":"2021","journal-title":"Hepatobiliary Pancreat Dis Int"},{"key":"10.1016\/j.jhepr.2022.100479_bib208","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.cmet.2018.08.020","article-title":"Inhibition of acetyl-CoA carboxylase by phosphorylation or the inhibitor ND-654 suppresses lipogenesis and hepatocellular carcinoma","volume":"29","author":"Lally","year":"2019","journal-title":"Cell Metab"},{"key":"10.1016\/j.jhepr.2022.100479_bib209","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1002\/hep.28415","article-title":"Acetyl-coenzyme A carboxylase alpha promotion of glucose-mediated fatty acid synthesis enhances survival of hepatocellular carcinoma in mice and patients","volume":"63","author":"Wang","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2022.100479_bib210","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1016\/j.ejca.2004.12.037","article-title":"Co-ordinate activation of lipogenic enzymes in hepatocellular carcinoma","volume":"41","author":"Yahagi","year":"2005","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.jhepr.2022.100479_bib211","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1002\/hep.31000","article-title":"Fatty acid synthase inhibitor TVB-2640 reduces hepatic de Novo lipogenesis in males with metabolic abnormalities","volume":"72","author":"Syed-Abdul","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2022.100479_bib212","doi-asserted-by":"crossref","first-page":"2437","DOI":"10.1038\/s41388-020-1156-0","article-title":"Stabilization of FASN by ACAT1-mediated GNPAT acetylation promotes lipid metabolism and hepatocarcinogenesis","volume":"39","author":"Gu","year":"2020","journal-title":"Oncogene"},{"key":"10.1016\/j.jhepr.2022.100479_bib213","doi-asserted-by":"crossref","first-page":"e75980","DOI":"10.1371\/journal.pone.0075980","article-title":"Cerulenin blockade of fatty acid synthase reverses hepatic steatosis in ob\/ob mice","volume":"8","author":"Cheng","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jhepr.2022.100479_bib214","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1080\/15384101.2018.1460023","article-title":"Metabolic reprogramming enables hepatocarcinoma cells to efficiently adapt and survive to a nutrient-restricted microenvironment","volume":"17","author":"Cassim","year":"2018","journal-title":"Cell Cycle"},{"key":"10.1016\/j.jhepr.2022.100479_bib215","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.jhep.2021.02.027","article-title":"Fructose- and sucrose- but not glucose-sweetened beverages promote hepatic de novo lipogenesis: a randomized controlled trial","volume":"75","author":"Geidl-Flueck","year":"2021","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhepr.2022.100479_bib216","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1136\/gutjnl-2018-317581","article-title":"Cholesterol biosynthesis supports the growth of hepatocarcinoma lesions depleted of fatty acid synthase in mice and humans","volume":"69","author":"Che","year":"2020","journal-title":"Gut"},{"key":"10.1016\/j.jhepr.2022.100479_bib217","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1186\/s12935-020-01520-4","article-title":"NONO promotes hepatocellular carcinoma progression by enhancing fatty acids biosynthesis through interacting with ACLY mRNA","volume":"20","author":"Ding","year":"2020","journal-title":"Cancer Cell Int"},{"key":"10.1016\/j.jhepr.2022.100479_bib218","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.3892\/or.2014.3484","article-title":"Expression and roles of fatty acid synthase in hepatocellular carcinoma","volume":"32","author":"Hao","year":"2014","journal-title":"Oncol Rep"},{"key":"10.1016\/j.jhepr.2022.100479_bib219","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.cmet.2017.07.009","article-title":"Acetyl CoA carboxylase inhibition reduces hepatic steatosis but elevates plasma triglycerides in mice and humans: a bedside to bench investigation","volume":"26","author":"Kim","year":"2017","journal-title":"Cell Metab"},{"key":"10.1016\/j.jhepr.2022.100479_bib220","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/j.jhep.2020.04.037","article-title":"Acetyl-CoA carboxylase inhibition disrupts metabolic reprogramming during hepatic stellate cell activation","volume":"73","author":"Bates","year":"2020","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhepr.2022.100479_bib221","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.molmet.2014.02.004","article-title":"Genetic inhibition of hepatic acetyl-CoA carboxylase activity increases liver fat and alters global protein acetylation","volume":"3","author":"Chow","year":"2014","journal-title":"Mol Metab"},{"key":"10.1016\/j.jhepr.2022.100479_bib222","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.jhep.2015.10.004","article-title":"Inactivation of fatty acid synthase impairs hepatocarcinogenesis driven by AKT in mice and humans","volume":"64","author":"Li","year":"2016","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhepr.2022.100479_bib223","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.3389\/fonc.2020.01025","article-title":"KDM5C represses FASN-mediated lipid metabolism to exert tumor suppressor activity in intrahepatic cholangiocarcinoma","volume":"10","author":"Zhang","year":"2020","journal-title":"Front Oncol"},{"key":"10.1016\/j.jhepr.2022.100479_bib224","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.canlet.2014.12.036","article-title":"SCD1 negatively regulates autophagy-induced cell death in human hepatocellular carcinoma through inactivation of the AMPK signaling pathway","volume":"358","author":"Huang","year":"2015","journal-title":"Cancer Lett"},{"key":"10.1016\/j.jhepr.2022.100479_bib225","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1093\/carcin\/23.11.1933","article-title":"Stearoyl-CoA desaturase 1 (Scd1) gene overexpression is associated with genetic predisposition to hepatocarcinogenesis in mice and rats","volume":"23","author":"Falvella","year":"2002","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.jhepr.2022.100479_bib226","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1038\/s41586-019-0904-1","article-title":"Evidence for an alternative fatty acid desaturation pathway increasing cancer plasticity","volume":"566","author":"Vriens","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.jhepr.2022.100479_bib227","doi-asserted-by":"crossref","first-page":"6586","DOI":"10.1038\/s41598-018-24633-3","article-title":"Elovl6 is a negative clinical predictor for liver cancer and knockdown of Elovl6 reduces murine liver cancer progression","volume":"8","author":"Su","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.jhepr.2022.100479_bib228","doi-asserted-by":"crossref","first-page":"108950","DOI":"10.1016\/j.biopha.2019.108950","article-title":"Dgat2 reduces hepatocellular carcinoma malignancy via downregulation of cell cycle-related gene expression","volume":"115","author":"Li","year":"2019","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.jhepr.2022.100479_bib229","doi-asserted-by":"crossref","first-page":"101168","DOI":"10.1016\/j.molmet.2021.101168","article-title":"Hypoxia-inducible lipid droplet-associated induces DGAT1 and promotes lipid storage in hepatocytes","volume":"47","author":"de la Rosa Rodriguez","year":"2021","journal-title":"Mol Metab"},{"key":"10.1016\/j.jhepr.2022.100479_bib230","article-title":"Histone demethylase KDM7A contributes to the development of hepatic steatosis by targeting diacylglycerol acyltransferase 2","volume":"22","author":"Kim","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jhepr.2022.100479_bib231","doi-asserted-by":"crossref","first-page":"8681","DOI":"10.1039\/D1FO01472B","article-title":"CD36 and DGAT2 facilitate the lipid-lowering effect of chitooligosaccharides via fatty acid intake and triglyceride synthesis signaling","volume":"12","author":"Shen","year":"2021","journal-title":"Food Funct"},{"key":"10.1016\/j.jhepr.2022.100479_bib232","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1111\/jcmm.12685","article-title":"Prolonged silencing of diacylglycerol acyltransferase-1 induces a dedifferentiated phenotype in human liver cells","volume":"20","author":"Chang","year":"2016","journal-title":"J\u00a0Cell Mol Med"},{"key":"10.1016\/j.jhepr.2022.100479_bib233","doi-asserted-by":"crossref","first-page":"158991","DOI":"10.1016\/j.bbalip.2021.158991","article-title":"DGAT2 stability is increased in response to DGAT1 inhibition in gene edited HepG2 cells","volume":"1866","author":"McFie","year":"2021","journal-title":"Biochim Biophys Acta Mol Cell Biol Lipids"},{"key":"10.1016\/j.jhepr.2022.100479_bib234","article-title":"An RNAi therapeutic targeting hepatic DGAT2 in a genetically obese mouse model of nonalcoholic steatohepatitis","author":"Yenilmez","year":"2021","journal-title":"Mol Ther"},{"key":"10.1016\/j.jhepr.2022.100479_bib235","doi-asserted-by":"crossref","DOI":"10.1096\/fj.201700717RR","article-title":"Epigenetic programming at the Mogat1 locus may link neonatal overnutrition with long-term hepatic steatosis and insulin resistance","author":"Ramon-Krauel","year":"2018","journal-title":"FASEB J"},{"key":"10.1016\/j.jhepr.2022.100479_bib236","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1530\/JOE-16-0447","article-title":"Hepatocyte-specific, PPARgamma-regulated mechanisms to promote steatosis in adult mice","volume":"232","author":"Wolf Greenstein","year":"2017","journal-title":"J\u00a0Endocrinol"},{"key":"10.1016\/j.jhepr.2022.100479_bib237","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1194\/jlr.P025536","article-title":"Evidence for regulated monoacylglycerol acyltransferase expression and activity in human liver","volume":"53","author":"Hall","year":"2012","journal-title":"J\u00a0Lipid Res"},{"key":"10.1016\/j.jhepr.2022.100479_bib238","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.canlet.2018.08.006","article-title":"Fatty acid oxidation: an emerging facet of metabolic transformation in cancer","volume":"435","author":"Ma","year":"2018","journal-title":"Cancer Lett"},{"key":"10.1016\/j.jhepr.2022.100479_bib239","doi-asserted-by":"crossref","first-page":"2780","DOI":"10.1016\/j.celrep.2017.02.033","article-title":"Integrative genomic analysis of cholangiocarcinoma identifies distinct IDH-mutant molecular profiles","volume":"18","author":"Farshidfar","year":"2017","journal-title":"Cell Rep"},{"key":"10.1016\/j.jhepr.2022.100479_bib240","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1016\/j.cell.2017.05.046","article-title":"Comprehensive and integrative genomic characterization of hepatocellular carcinoma","volume":"169","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.jhepr.2022.100479_bib241","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1136\/gutjnl-2017-315193","article-title":"CPT2 downregulation adapts HCC to lipid-rich environment and promotes carcinogenesis via acylcarnitine accumulation in obesity","volume":"67","author":"Fujiwara","year":"2018","journal-title":"Gut"},{"key":"10.1016\/j.jhepr.2022.100479_bib242","doi-asserted-by":"crossref","first-page":"2874","DOI":"10.1158\/0008-5472.CAN-20-2052","article-title":"E2F1 and E2F2-mediated repression of CPT2 establishes a lipid-rich tumor-promoting environment","volume":"81","author":"Gonzalez-Romero","year":"2021","journal-title":"Cancer Res"},{"key":"10.1016\/j.jhepr.2022.100479_bib243","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1038\/s41419-021-03648-1","article-title":"Down-regulation of SLC25A20 promotes hepatocellular carcinoma growth and metastasis through suppression of fatty-acid oxidation","volume":"12","author":"Yuan","year":"2021","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.jhepr.2022.100479_bib244","article-title":"Suppression of ACADM-mediated fatty acid oxidation promotes hepatocellular carcinoma via aberrant Cav1\/SREBP-1 signaling","author":"Ma","year":"2021","journal-title":"Cancer Res"},{"key":"10.1016\/j.jhepr.2022.100479_bib245","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/s41698-020-0111-4","article-title":"ACADL plays a tumor-suppressor role by targeting Hippo\/YAP signaling in hepatocellular carcinoma","volume":"4","author":"Zhao","year":"2020","journal-title":"NPJ Precis Oncol"},{"key":"10.1016\/j.jhepr.2022.100479_bib246","first-page":"3270","article-title":"Increase in the active form of 3-hydroxy-3-methylglutaryl coenzyme A reductase in human hepatocellular carcinoma: possible mechanism for alteration of cholesterol biosynthesis","volume":"50","author":"Kawata","year":"1990","journal-title":"Cancer Res"},{"key":"10.1016\/j.jhepr.2022.100479_bib247","doi-asserted-by":"crossref","first-page":"696961","DOI":"10.3389\/fphar.2021.696961","article-title":"Targeting fatty acid synthase modulates metabolic pathways and inhibits cholangiocarcinoma cell progression","volume":"12","author":"Tomacha","year":"2021","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.jhepr.2022.100479_bib248","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1053\/j.gastro.2012.10.005","article-title":"Statins are associated with a reduced risk of hepatocellular cancer: a systematic review and meta-analysis","volume":"144","author":"Singh","year":"2013","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhepr.2022.100479_bib249","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aap9840","article-title":"Squalene epoxidase drives NAFLD-induced hepatocellular carcinoma and is a pharmaceutical target","volume":"10","author":"Liu","year":"2018","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.jhepr.2022.100479_bib250","doi-asserted-by":"crossref","first-page":"101230","DOI":"10.1016\/j.molmet.2021.101230","article-title":"LDLR inhibition promotes hepatocellular carcinoma proliferation and metastasis by elevating intracellular cholesterol synthesis through the MEK\/ERK signaling pathway","volume":"51","author":"Chen","year":"2021","journal-title":"Mol Metab"},{"key":"10.1016\/j.jhepr.2022.100479_bib251","doi-asserted-by":"crossref","first-page":"16492","DOI":"10.1073\/pnas.2002672117","article-title":"JNK-mediated disruption of bile acid homeostasis promotes intrahepatic cholangiocarcinoma","volume":"117","author":"Manieri","year":"2020","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jhepr.2022.100479_bib252","article-title":"Serum metabolomics to identify the liver disease-specific biomarkers for the progression of hepatitis to hepatocellular carcinoma","volume":"5","author":"Gao","year":"2015","journal-title":"Scientific Rep"},{"key":"10.1016\/j.jhepr.2022.100479_bib253","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1172\/JCI105200","article-title":"Effects of prolonged ethanol intake: production of fatty liver despite adequate diets","volume":"44","author":"Lieber","year":"1965","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jhepr.2022.100479_bib254","doi-asserted-by":"crossref","first-page":"276","DOI":"10.3389\/fphar.2019.00276","article-title":"Metabolomics and lipidomics reveal the effect of hepatic Vps33b deficiency on bile acids and lipids metabolism","volume":"10","author":"Fu","year":"2019","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.jhepr.2022.100479_bib255","doi-asserted-by":"crossref","first-page":"6738","DOI":"10.1038\/s41598-020-62609-4","article-title":"Association between hepatitis B virus infection and metabolic syndrome in Southwest China: a cross-sectional study","volume":"10","author":"Yan","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.jhepr.2022.100479_bib256","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1186\/s12879-015-1268-2","article-title":"Changes in circulating lipids level over time after acquiring HCV infection: results from ERCHIVES","volume":"15","author":"Butt","year":"2015","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.jhepr.2022.100479_bib257","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.7314\/APJCP.2012.13.5.1963","article-title":"The metabolic syndrome and risk factors for biliary tract cancer: a case-control study in China","volume":"13","author":"Wu","year":"2012","journal-title":"Asian Pac J Cancer Prev"},{"key":"10.1016\/j.jhepr.2022.100479_bib258","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1186\/s12944-018-0898-y","article-title":"Effect of serum triglyceride level on the prognosis of patients with hepatocellular carcinoma in the absence of cirrhosis","volume":"17","author":"Liu","year":"2018","journal-title":"Lipids Health Dis"},{"key":"10.1016\/j.jhepr.2022.100479_bib259","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.aca.2012.07.013","article-title":"Utilization of metabolomics to identify serum biomarkers for hepatocellular carcinoma in patients with liver cirrhosis","volume":"743","author":"Ressom","year":"2012","journal-title":"Anal Chim Acta"},{"key":"10.1016\/j.jhepr.2022.100479_bib260","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1039\/C5MB00572H","article-title":"Serum metabolomics uncovering specific metabolite signatures of intra- and extrahepatic cholangiocarcinoma","volume":"12","author":"Liang","year":"2016","journal-title":"Mol Biosyst"},{"key":"10.1016\/j.jhepr.2022.100479_bib261","doi-asserted-by":"crossref","first-page":"e0228212","DOI":"10.1371\/journal.pone.0228212","article-title":"Acetyl-CoA carboxylase 1 and 2 inhibition ameliorates steatosis and hepatic fibrosis in a MC4R knockout murine model of nonalcoholic steatohepatitis","volume":"15","author":"Matsumoto","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.jhepr.2022.100479_bib262","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1080\/13543784.2020.1668374","article-title":"GS-0976 (Firsocostat): an investigational liver-directed acetyl-CoA carboxylase (ACC) inhibitor for the treatment of non-alcoholic steatohepatitis (NASH)","volume":"29","author":"Alkhouri","year":"2020","journal-title":"Expert Opin Investig Drugs"},{"key":"10.1016\/j.jhepr.2022.100479_bib263","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1016\/j.cgh.2018.04.042","article-title":"Acetyl-CoA carboxylase inhibitor GS-0976 for 12 weeks reduces hepatic de novo lipogenesis and steatosis in patients with nonalcoholic steatohepatitis","volume":"16","author":"Lawitz","year":"2018","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jhepr.2022.100479_bib264","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1002\/hep.29246","article-title":"Acetyl-coenzyme A carboxylase inhibition reduces de novo lipogenesis in overweight male subjects: a randomized, double-blind, crossover study","volume":"66","author":"Stiede","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2022.100479_bib265","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1053\/j.gastro.2021.07.025","article-title":"TVB-2640 (FASN inhibitor) for the treatment of nonalcoholic steatohepatitis: FASCINATE-1, a randomized, placebo-controlled phase 2a trial","volume":"161","author":"Loomba","year":"2021","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhepr.2022.100479_bib266","doi-asserted-by":"crossref","first-page":"60","DOI":"10.3346\/jkms.2017.32.1.60","article-title":"Lobeglitazone, a novel thiazolidinedione, improves non-alcoholic fatty liver disease in type 2 diabetes: its efficacy and predictive factors related to responsiveness","volume":"32","author":"Lee","year":"2017","journal-title":"J\u00a0Korean Med Sci"},{"key":"10.1016\/j.jhepr.2022.100479_bib267","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1254\/jphs.FM0070063","article-title":"Life style-related diseases of the digestive system: gene expression in nonalcoholic steatohepatitis patients and treatment strategies","volume":"105","author":"Yoneda","year":"2007","journal-title":"J\u00a0Pharmacol Sci"},{"key":"10.1016\/j.jhepr.2022.100479_bib268","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1056\/NEJMoa2036205","article-title":"A\u00a0randomized, controlled trial of the pan-PPAR agonist lanifibranor in NASH","volume":"385","author":"Francque","year":"2021","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jhepr.2022.100479_bib269","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1053\/j.gastro.2016.01.038","article-title":"Elafibranor, an agonist of the peroxisome proliferator-activated receptor-alpha and -delta, induces resolution of nonalcoholic steatohepatitis without fibrosis worsening","volume":"150","author":"Ratziu","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhepr.2022.100479_bib270","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1111\/apt.13981","article-title":"Randomised clinical trial: the efficacy and safety of oltipraz, a liver X receptor alpha-inhibitory dithiolethione in patients with non-alcoholic fatty liver disease","volume":"45","author":"Kim","year":"2017","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jhepr.2022.100479_bib271","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/S0140-6736(14)61933-4","article-title":"Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial","volume":"385","author":"Neuschwander-Tetri","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.jhepr.2022.100479_bib272","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.jhep.2020.02.033","article-title":"A\u00a0randomized, placebo-controlled, phase II study of obeticholic acid for primary sclerosing cholangitis","volume":"73","author":"Kowdley","year":"2020","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhepr.2022.100479_bib273","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1007\/s00508-020-01735-5","article-title":"Open-label phase II study evaluating safety and efficacy of the non-steroidal farnesoid X receptor agonist PX-104 in non-alcoholic fatty liver disease","volume":"133","author":"Traussnigg","year":"2021","journal-title":"Wien Klin Wochenschr"},{"key":"10.1016\/j.jhepr.2022.100479_bib274","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.jhep.2021.01.047","article-title":"A\u00a0structurally optimized FXR agonist, MET409, reduced liver fat content over 12 weeks in patients with non-alcoholic steatohepatitis","volume":"75","author":"Harrison","year":"2021","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhepr.2022.100479_bib275","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1111\/liv.14209","article-title":"CONTROL: a randomized phase 2 study of obeticholic acid and atorvastatin on lipoproteins in nonalcoholic steatohepatitis patients","volume":"39","author":"Pockros","year":"2019","journal-title":"Liver Int"},{"key":"10.1016\/j.jhepr.2022.100479_bib276","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bbrc.2021.09.060","article-title":"The alleviating effect of sphingosine kinases 2 inhibitor K145 on nonalcoholic fatty liver","volume":"580","author":"Shi","year":"2021","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.jhepr.2022.100479_bib277","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1194\/jlr.M093799","article-title":"FTY720\/fingolimod decreases hepatic steatosis and expression of fatty acid synthase in diet-induced nonalcoholic fatty liver disease in mice","volume":"60","author":"Rohrbach","year":"2019","journal-title":"J\u00a0Lipid Res"},{"key":"10.1016\/j.jhepr.2022.100479_bib278","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.bbabio.2010.12.002","article-title":"AICAR inhibits cancer cell growth and triggers cell-type distinct effects on OXPHOS biogenesis, oxidative stress and Akt activation","volume":"1807","author":"Jose","year":"2011","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.jhepr.2022.100479_bib279","doi-asserted-by":"crossref","first-page":"114918","DOI":"10.1016\/j.taap.2020.114918","article-title":"Orlistat delays hepatocarcinogenesis in mice with hepatic co-activation of AKT and c-Met","volume":"392","author":"Zhang","year":"2020","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1016\/j.jhepr.2022.100479_bib280","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1021\/acs.chemrestox.8b00269","article-title":"Orlistat displays antitumor activity and enhances the efficacy of paclitaxel in human hepatoma Hep3B cells","volume":"32","author":"You","year":"2019","journal-title":"Chem Res Toxicol"},{"key":"10.1016\/j.jhepr.2022.100479_bib281","doi-asserted-by":"crossref","first-page":"978","DOI":"10.4161\/cbt.5.8.2883","article-title":"Growth arrest induced by C75, A fatty acid synthase inhibitor, was partially modulated by p38 MAPK but not by p53 in human hepatocellular carcinoma","volume":"5","author":"Gao","year":"2006","journal-title":"Cancer Biol Ther"},{"key":"10.1016\/j.jhepr.2022.100479_bib282","doi-asserted-by":"crossref","first-page":"e22413","DOI":"10.1002\/jbt.22413","article-title":"The modulatory effect of triclosan on the reversion of the activated phenotype of LX-2 hepatic stellate cells","volume":"34","author":"Miranda","year":"2020","journal-title":"J\u00a0Biochem Mol Toxicol"},{"key":"10.1016\/j.jhepr.2022.100479_bib283","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1002\/mnfr.200800592","article-title":"EGCG inhibits protein synthesis, lipogenesis, and cell cycle progression through activation of AMPK in p53 positive and negative human hepatoma cells","volume":"53","author":"Huang","year":"2009","journal-title":"Mol Nutr Food Res"},{"key":"10.1016\/j.jhepr.2022.100479_bib284","doi-asserted-by":"crossref","DOI":"10.1007\/s11010-021-04167-5","article-title":"Modulation of SCD1 activity in hepatocyte cell lines: evaluation of genomic stability and proliferation","author":"de Lima Luna","year":"2021","journal-title":"Mol Cell Biochem"},{"key":"10.1016\/j.jhepr.2022.100479_bib285","doi-asserted-by":"crossref","first-page":"7350","DOI":"10.18632\/aging.103082","article-title":"Inhibition of stearoyl-coenzyme A desaturase 1 ameliorates hepatic steatosis by inducing AMPK-mediated lipophagy","volume":"12","author":"Zhou","year":"2020","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.jhepr.2022.100479_bib286","doi-asserted-by":"crossref","first-page":"10493","DOI":"10.1021\/jf801978r","article-title":"Sesquiterpenoids isolated from the flower buds of Tussilago farfara L. inhibit diacylglycerol acyltransferase","volume":"56","author":"Park","year":"2008","journal-title":"J\u00a0Agric Food Chem"},{"key":"10.1016\/j.jhepr.2022.100479_bib287","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1111\/j.1742-1241.2010.02414.x","article-title":"Design and rationale for the non-interventional global investigation of therapeutic DEcisions in hepatocellular carcinoma and of its treatment with sorafenib (GIDEON) study","volume":"64","author":"Lencioni","year":"2010","journal-title":"Int J Clin Pract"},{"key":"10.1016\/j.jhepr.2022.100479_bib288","doi-asserted-by":"crossref","first-page":"10089","DOI":"10.1096\/fj.201802619RR","article-title":"Sorafenib kills liver cancer cells by disrupting SCD1-mediated synthesis of monounsaturated fatty acids via the ATP-AMPK-mTOR-SREBP1 signaling pathway","volume":"33","author":"Liu","year":"2019","journal-title":"FASEB J"},{"key":"10.1016\/j.jhepr.2022.100479_bib289","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/j.jhep.2017.06.015","article-title":"Stearoyl-CoA desaturase regulates sorafenib resistance via modulation of ER stress-induced differentiation","volume":"67","author":"Ma","year":"2017","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhepr.2022.100479_bib290","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.canlet.2018.10.024","article-title":"Diet-induced hepatic steatosis activates Ras to promote hepatocarcinogenesis via CPT1alpha","volume":"442","author":"Xu","year":"2019","journal-title":"Cancer Lett"},{"key":"10.1016\/j.jhepr.2022.100479_bib291","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1093\/toxsci\/68.1.93","article-title":"Etomoxir-induced oxidative stress in HepG2 cells detected by differential gene expression is confirmed biochemically","volume":"68","author":"Merrill","year":"2002","journal-title":"Toxicol Sci"},{"key":"10.1016\/j.jhepr.2022.100479_bib292","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1038\/s41420-021-00504-1","article-title":"Simultaneously targeting SOAT1 and CPT1A ameliorates hepatocellular carcinoma by disrupting lipid homeostasis","volume":"7","author":"Ren","year":"2021","journal-title":"Cell Death Discov"},{"key":"10.1016\/j.jhepr.2022.100479_bib293","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1038\/s41419-019-1884-7","article-title":"SREBP-1 inhibitor Betulin enhances the antitumor effect of Sorafenib on hepatocellular carcinoma via restricting cellular glycolytic activity","volume":"10","author":"Yin","year":"2019","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.jhepr.2022.100479_bib294","doi-asserted-by":"crossref","first-page":"11203","DOI":"10.1038\/s41598-017-11549-7","article-title":"Long-term administration of nuclear bile acid receptor FXR agonist prevents spontaneous hepatocarcinogenesis in Abcb4(-\/-) mice","volume":"7","author":"Cariello","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.jhepr.2022.100479_bib295","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s13046-020-1528-x","article-title":"Simvastatin re-sensitizes hepatocellular carcinoma cells to sorafenib by inhibiting HIF-1alpha\/PPAR-gamma\/PKM2-mediated glycolysis","volume":"39","author":"Feng","year":"2020","journal-title":"J\u00a0Exp Clin Cancer Res"},{"key":"10.1016\/j.jhepr.2022.100479_bib296","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.jhep.2019.04.021","article-title":"Pravastatin combination with sorafenib does not improve survival in advanced hepatocellular carcinoma","volume":"71","author":"Jouve","year":"2019","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhepr.2022.100479_bib297","doi-asserted-by":"crossref","first-page":"20080","DOI":"10.18632\/oncotarget.7914","article-title":"Antitumor effect of the novel sphingosine kinase 2 inhibitor ABC294640 is enhanced by inhibition of autophagy and by sorafenib in human cholangiocarcinoma cells","volume":"7","author":"Ding","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.jhepr.2022.100479_bib298","first-page":"546","article-title":"Targeting sphingosine kinase 2 suppresses cell growth and synergizes with BCL2\/BCL-XL inhibitors through NOXA-mediated MCL1 degradation in cholangiocarcinoma","volume":"9","author":"Ding","year":"2019","journal-title":"Am J Cancer Res"},{"key":"10.1016\/j.jhepr.2022.100479_bib299","doi-asserted-by":"crossref","first-page":"524","DOI":"10.4161\/cbt.11.5.14677","article-title":"Antitumor activity of sphingosine kinase 2 inhibitor ABC294640 and sorafenib in hepatocellular carcinoma xenografts","volume":"11","author":"Beljanski","year":"2011","journal-title":"Cancer Biol Ther"},{"key":"10.1016\/j.jhepr.2022.100479_bib300","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.jconrel.2015.08.022","article-title":"Enhanced antitumour drug delivery to cholangiocarcinoma through the apical sodium-dependent bile acid transporter (ASBT)","volume":"216","author":"Lozano","year":"2015","journal-title":"J\u00a0Control Release"},{"key":"10.1016\/j.jhepr.2022.100479_bib301","doi-asserted-by":"crossref","first-page":"e0210077","DOI":"10.1371\/journal.pone.0210077","article-title":"The FXR agonist obeticholic acid inhibits the cancerogenic potential of human cholangiocarcinoma","volume":"14","author":"Di Matteo","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.jhepr.2022.100479_bib302","doi-asserted-by":"crossref","first-page":"8105735","DOI":"10.1155\/2020\/8105735","article-title":"Revisiting the Warburg effect: diet-based strategies for cancer prevention","volume":"2020","author":"Tran","year":"2020","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.jhepr.2022.100479_bib303","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.metabol.2016.10.002","article-title":"Amelioration of non-alcoholic fatty liver disease with NPC1L1-targeted IgY or n-3 polyunsaturated fatty acids in mice","volume":"66","author":"Bae","year":"2017","journal-title":"Metabolism"},{"key":"10.1016\/j.jhepr.2022.100479_bib304","first-page":"685","article-title":"Ethyl-eicosapentaenoic acid reduces liver lipids and lowers plasma levels of lipids in mice fed a high-fat diet","volume":"23","author":"Nemoto","year":"2009","journal-title":"In\u00a0Vivo"},{"key":"10.1016\/j.jhepr.2022.100479_bib305","doi-asserted-by":"crossref","first-page":"e0121528","DOI":"10.1371\/journal.pone.0121528","article-title":"Eicosapentaenoic acid ameliorates non-alcoholic steatohepatitis in a novel mouse model using melanocortin 4 receptor-deficient mice","volume":"10","author":"Konuma","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.jhepr.2022.100479_bib306","first-page":"367","article-title":"Fish consumption and n-3 polyunsaturated fatty acids, and risk of hepatocellular carcinoma: systematic review and meta-analysis","volume":"26","author":"Gao","year":"2015","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.jhepr.2022.100479_bib307","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.bbalip.2017.11.002","article-title":"Omega-3 polyunsaturated fatty acids protect human hepatoma cells from developing steatosis through FFA4 (GPR120)","volume":"1863","author":"Kang","year":"2018","journal-title":"Biochim Biophys Acta Mol Cell Biol Lipids"},{"key":"10.1016\/j.jhepr.2022.100479_bib308","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1093\/carcin\/bgr049","article-title":"Suppressed liver tumorigenesis in fat-1 mice with elevated omega-3\u00a0fatty acids is associated with increased omega-3 derived lipid\u00a0mediators and reduced TNF-alpha","volume":"32","author":"Weylandt","year":"2011","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.jhepr.2022.100479_bib309","doi-asserted-by":"crossref","first-page":"10953","DOI":"10.1038\/s41598-018-29222-y","article-title":"Substitution of linoleic acid with alpha-linolenic acid or long chain n-3 polyunsaturated fatty acid prevents Western diet induced nonalcoholic steatohepatitis","volume":"8","author":"Jeyapal","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.jhepr.2022.100479_bib310","doi-asserted-by":"crossref","first-page":"e46400","DOI":"10.1371\/journal.pone.0046400","article-title":"N-3 long-chain polyunsaturated fatty acid supplementation significantly reduces liver oxidative stress in high fat induced steatosis","volume":"7","author":"Valenzuela","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.jhepr.2022.100479_bib311","doi-asserted-by":"crossref","first-page":"4992","DOI":"10.1158\/0008-5472.CAN-13-0308","article-title":"Metabolic characterization of hepatocellular carcinoma using nontargeted tissue metabolomics","volume":"73","author":"Huang","year":"2013","journal-title":"Cancer Res"},{"key":"10.1016\/j.jhepr.2022.100479_bib312","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21010040","article-title":"Sphingolipids in non-alcoholic fatty liver disease and hepatocellular carcinoma: ceramide turnover","volume":"21","author":"Simon","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jhepr.2022.100479_bib313","doi-asserted-by":"crossref","first-page":"3046","DOI":"10.1158\/1535-7163.MCT-09-0551","article-title":"Omega-3 polyunsaturated fatty acids\u00a0inhibit hepatocellular carcinoma cell growth through blocking\u00a0beta-catenin and cyclooxygenase-2","volume":"8","author":"Lim","year":"2009","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.jhepr.2022.100479_bib314","doi-asserted-by":"crossref","first-page":"6590","DOI":"10.1158\/0008-5472.CAN-11-0885","article-title":"Aberrant lipid metabolism in hepatocellular carcinoma revealed by\u00a0plasma metabolomics and lipid profiling","volume":"71","author":"Patterson","year":"2011","journal-title":"Cancer Res"}],"container-title":["JHEP Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589555922000519?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589555922000519?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T22:28:12Z","timestamp":1762900092000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589555922000519"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":314,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["S2589555922000519"],"URL":"https:\/\/doi.org\/10.1016\/j.jhepr.2022.100479","relation":{},"ISSN":["2589-5559"],"issn-type":[{"value":"2589-5559","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lipid alterations in chronic liver disease and liver cancer","name":"articletitle","label":"Article Title"},{"value":"JHEP Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhepr.2022.100479","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s). Published by Elsevier B.V. on behalf of European Association for the Study of the Liver (EASL).","name":"copyright","label":"Copyright"}],"article-number":"100479"}}